Our site may be slower due to heavy traffic from automated "bots" and AI crawlers. We're working to fix this.

Daniel Porte

Title(s)Clinical Professor (Voluntary), Medicine
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Diabetes knowledge, risk and severity perceptions, lifestyle behaviours and management barriers among Sub-Saharan African immigrants living in the UK: an ethnographic study. BMC Public Health. 2025 Aug 22; 25(1):2883. Onuorah L, Santy-Tomlinson J, Draper P. PMID: 40846934; PMCID: PMC12372270.
      View in: PubMed   Mentions:    Fields:    
    2. Graduate Students' Perspectives on Obtaining a Master's of Science in Respiratory Care. Respir Care. 2025 04; 70(4):384-392. Koster MS, McHenry KL, Caldwell-Chadwick BG, Null MM. PMID: 40193534.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Comparative risk of QTc prolongation induced by second-generation antipsychotics in the real world: retrospective cohort study based on a hospital information system. BJPsych Open. 2025 Mar 10; 11(2):e42. He L, Yu W, Song H, Li L, Shen Y, Zhang L, Li H. PMID: 40059385; PMCID: PMC12001931.
      View in: PubMed   Mentions:
    4. Association of Lower Rostral Anterior Cingulate GABA+ and Dysregulated Cortisol Stress Response With Altered Functional Connectivity in Young Adults With Lifetime Depression: A Multimodal Imaging Investigation of Trait and State Effects. Am J Psychiatry. 2024 Jul 01; 181(7):639-650. Ironside M, Duda JM, Moser AD, Holsen LM, Zuo CS, Du F, Perlo S, Richards CE, Chen X, Chen X, Nickerson LD, Null KE, Esfand SM, Alexander MM, Crowley DJ, Lauze M, Misra M, Goldstein JM, Pizzagalli DA. PMID: 38685857; PMCID: PMC11216878.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    5. [Determination of trace anions in battery-grade lithium carbonate by double-inhibition on-line matrix-removal ion chromatography]. Se Pu. 2024 Mar 08; 42(3):291-295. Wu G, Wu G, Wu GQ. PMID: 38503706; PMCID: PMC10951807.
      View in: PubMed   Mentions:    Fields:    
    6. Porcine reproductive and respiratory syndrome virus degrades DDX10 via SQSTM1/p62-dependent selective autophagy to antagonize its antiviral activity. Autophagy. 2023 08; 19(8):2257-2274. Li J, Li J, Zhou Y, Zhao W, Zhao W, Liu J, Liu J, Ullah R, Fang P, Fang L, Xiao S. PMID: 36779599; PMCID: PMC10351467.
      View in: PubMed   Mentions: 23     Fields:    Translation:AnimalsCells
    7. [Determination of organophosphate diesters in facility vegetable soils using ultra-high performance liquid chromatography-electrostatic field orbitrap high resolution mass spectrometry]. Se Pu. 2023 Jan; 41(1):58-65. Liu M, Wang M, Zhao A, Zhao A, Zhu L, Wang C, Wei C, Liu W, Liu W, Xu J. PMID: 36633077; PMCID: PMC9837671.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    8. [Simultaneous determination of 28 fragrance components in cosmetics by gas chromatography-tandem mass spectrometry]. Se Pu. 2023 Jan; 41(1):76-86. Xu D, Wu Y, Wu Y, Wang Y, Chen F, Chen F, Zhang S, Lai G. PMID: 36633079; PMCID: PMC9841437.
      View in: PubMed   Mentions: 1     Fields:    
    9. DBI/ACBP is a targetable autophagy checkpoint involved in aging and cardiovascular disease. Autophagy. 2023 07; 19(7):2166-2169. Montégut L, Joseph A, Chen H, Chen H, Abdellatif M, Ruckenstuhl C, Martins I, Madeo F, Kroemer G. PMID: 36579946; PMCID: PMC10283417.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    10. Author Correction: Polycomb CBX7 has a unifying role in cellular lifespan. Nat Cell Biol. 2022 Sep; 24(9):1445. Gil J, Bernard D, Martínez D, Beach D. PMID: 35941232.
      View in: PubMed   Mentions: 1     Fields:    
    11. [Plasma metabolomics in a deep vein thrombosis rat model based on ultra-high performance liquid chromatography-electrostatic field orbitrap high resolution mass spectrometry]. Se Pu. 2022 Aug; 40(8):736-745. Gu Y, Zang P, Li J, Li J, Yan Y, Wang J. PMID: 35903841; PMCID: PMC9404070.
      View in: PubMed   Mentions: 6     Fields:    Translation:Animals
    12. Autophagy and its mediated mitochondrial quality control maintain pollen tube growth and male fertility in Arabidopsis. Autophagy. 2023 03; 19(3):768-783. Yan H, Zhuang M, Xu X, Li S, Li S, Yang M, Li N, Du X, Hu K, Peng X, Huang W, Wu H, Wu H, Tse YC, Zhao L, Wang H. PMID: 35786359; PMCID: PMC9980518.
      View in: PubMed   Mentions: 17     Fields:    Translation:AnimalsCells
    13. Uniform criteria for total hip replacement surgery in patients with hip osteoarthritis: a decision tool to guide treatment decisions. Int J Qual Health Care. 2021 Mar 04; 33(1). Atsma F, Molenkamp O, Bouma H, Bolder SB, Groenewoud AS, Westert GP. PMID: 33616656; PMCID: PMC7941208.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    14. Injury, Illness, and Mental Health Risks in United States Domestic Mariners. J Occup Environ Med. 2020 10; 62(10):839-841. Lefkowitz RY, Null DB, Slade MD, Redlich CA. PMID: 32769797.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    15. Imaging examination, diagnosis, and control and prevention of nosocomial infection for coronavirus disease 2019: Expert consensus of Hunan radiologist. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020 Mar 28; 45(3):221-228. Liu J, Liu J, Liu J, Wang W. PMID: 32386011.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsPHPublic Health
    16. A 12-week randomized clinical trial investigating the potential for sucralose to affect glucose homeostasis. Regul Toxicol Pharmacol. 2017 Aug; 88:22-33. Grotz VL, Pi-Sunyer X, Porte D, Roberts A, Richard Trout J. PMID: 28502831.
      View in: PubMed   Mentions:
    17. Insulin signaling in the central nervous system: a critical role in metabolic homeostasis and disease from C. elegans to humans. Diabetes. 2005 May; 54(5):1264-76. Porte D, Baskin DG, Schwartz MW. PMID: 15855309.
      View in: PubMed   Mentions:
    18. Diabetes, obesity, and the brain. Science. 2005 Jan 21; 307(5708):375-9. Schwartz MW, Porte D. PMID: 15662002.
      View in: PubMed   Mentions:
    19. Leptin and insulin action in the central nervous system. Nutr Rev. 2002 Oct; 60(10 Pt 2):S20-9; discussion S68-84, 85-7. Porte D, Baskin DG, Schwartz MW. PMID: 12403080.
      View in: PubMed   Mentions:
    20. Clinical importance of insulin secretion and its interaction with insulin resistance in the treatment of type 2 diabetes mellitus and its complications. Diabetes Metab Res Rev. 2001 May-Jun; 17(3):181-8. Porte D. PMID: 11424231.
      View in: PubMed   Mentions:
    21. Obesity, body fat distribution, insulin sensitivity and Islet beta-cell function as explanations for metabolic diversity. J Nutr. 2001 Feb; 131(2):354S-60S. Kahn SE, Prigeon RL, Schwartz RS, Fujimoto WY, Knopp RH, Brunzell JD, Porte D. PMID: 11160560.
      View in: PubMed   Mentions:
    22. beta-cell dysfunction and failure in type 2 diabetes: potential mechanisms. Diabetes. 2001 Feb; 50 Suppl 1:S160-3. Porte D, Kahn SE. PMID: 11272181.
      View in: PubMed   Mentions:
    23. Central nervous system control of food intake. Nature. 2000 Apr 06; 404(6778):661-71. Schwartz MW, Woods SC, Porte D, Seeley RJ, Baskin DG. PMID: 10766253.
      View in: PubMed   Mentions:
    24. Comments on the relation among GAD-65, IA-2 antibodies and body adiposity. Diabetologia. 2000 Jan; 43(1):134. Porte D, Seeley RJ, Woods SC, Baskin DG, Figlewicz DP, Schwartz MW. PMID: 10672457.
      View in: PubMed   Mentions:
    25. Insulin and leptin: dual adiposity signals to the brain for the regulation of food intake and body weight. Brain Res. 1999 Nov 27; 848(1-2):114-23. Baskin DG, Figlewicz Lattemann D, Seeley RJ, Woods SC, Porte D, Schwartz MW. PMID: 10612703.
      View in: PubMed   Mentions:
    26. Mechanisms for hyperglycemia in the metabolic syndrome. The key role of beta-cell dysfunction. Ann N Y Acad Sci. 1999 Nov 18; 892:73-83. Porte D. PMID: 10842653.
      View in: PubMed   Mentions:
    27. Reduced beta-cell function contributes to impaired glucose tolerance in dogs made obese by high-fat feeding. Am J Physiol. 1999 10; 277(4):E659-67. Kaiyala KJ, Prigeon RL, Kahn SE, Woods SC, Porte D, Schwartz MW. PMID: 10516125.
      View in: PubMed   Mentions:
    28. Leptin receptor long-form splice-variant protein expression in neuron cell bodies of the brain and co-localization with neuropeptide Y mRNA in the arcuate nucleus. J Histochem Cytochem. 1999 Mar; 47(3):353-62. Baskin DG, Schwartz MW, Seeley RJ, Woods SC, Porte D, Breininger JF, Jonak Z, Schaefer J, Krouse M, Burghardt C, Campfield LA, Burn P, Kochan JP. PMID: 10026237.
      View in: PubMed   Mentions:
    29. Obesity, diabetes and the central nervous system. Diabetologia. 1998 Aug; 41(8):863-81. Porte D, Seeley RJ, Woods SC, Baskin DG, Figlewicz DP, Schwartz MW. PMID: 9726588.
      View in: PubMed   Mentions:
    30. Signals that regulate food intake and energy homeostasis. Science. 1998 May 29; 280(5368):1378-83. Woods SC, Seeley RJ, Porte D, Schwartz MW. PMID: 9603721.
      View in: PubMed   Mentions:
    31. Effect of troglitazone on B cell function, insulin sensitivity, and glycemic control in subjects with type 2 diabetes mellitus. J Clin Endocrinol Metab. 1998 Mar; 83(3):819-23. Prigeon RL, Kahn SE, Porte D. PMID: 9506734.
      View in: PubMed   Mentions:
    32. Disproportionately elevated proinsulin levels reflect the degree of impaired B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1998 Feb; 83(2):604-8. Røder ME, Porte D, Schwartz RS, Kahn SE. PMID: 9467581.
      View in: PubMed   Mentions:
    33. Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype. Neurology. 1998 Jan; 50(1):164-8. Craft S, Peskind E, Schwartz MW, Schellenberg GD, Raskind M, Porte D. PMID: 9443474.
      View in: PubMed   Mentions:
    34. Evidence that plasma leptin and insulin levels are associated with body adiposity via different mechanisms. Diabetes Care. 1997 Sep; 20(9):1476-81. Schwartz MW, Prigeon RL, Kahn SE, Nicolson M, Moore J, Morawiecki A, Boyko EJ, Porte D. PMID: 9283801.
      View in: PubMed   Mentions:
    35. Normal physiology and phenotypic characterization of beta-cell function in subjects at risk for non-insulin-dependent diabetes mellitus. Diabet Med. 1996 Sep; 13(9 Suppl 6):S25-32. Porte D. PMID: 8894477.
      View in: PubMed   Mentions:
    36. Effect of sulfonylurea withdrawal on proinsulin levels, B cell function, and glucose disposal in subjects with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1996 Sep; 81(9):3295-8. Prigeon RL, Jacobson RK, Porte D, Kahn SE. PMID: 8784086.
      View in: PubMed   Mentions:
    37. Diabetes complications: why is glucose potentially toxic? Science. 1996 May 03; 272(5262):699-700. Porte D, Schwartz MW. PMID: 8614830.
      View in: PubMed   Mentions:
    38. Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans. Nat Med. 1996 May; 2(5):589-93. Schwartz MW, Peskind E, Raskind M, Boyko EJ, Porte D. PMID: 8616722.
      View in: PubMed   Mentions:
    39. Endocrine regulation of food intake and body weight. J Lab Clin Med. 1996 Apr; 127(4):328-32. Figlewicz DP, Schwartz MW, Seeley RJ, Chavez M, Baskin DG, Woods SC, Porte D. PMID: 8656034.
      View in: PubMed   Mentions:
    40. A variation at position -30 of the beta-cell glucokinase gene promoter is associated with reduced beta-cell function in middle-aged Japanese-American men. Diabetes. 1996 Apr; 45(4):422-8. Stone LM, Kahn SE, Fujimoto WY, Deeb SS, Porte D. PMID: 8603762.
      View in: PubMed   Mentions:
    41. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes. 1996 Apr; 45(4):531-5. Schwartz MW, Baskin DG, Bukowski TR, Kuijper JL, Foster D, Lasser G, Prunkard DE, Porte D, Woods SC, Seeley RJ, Weigle DS. PMID: 8603777.
      View in: PubMed   Mentions:
    42. Hyperproinsulinemia is associated with increased beta cell demand after hemipancreatectomy in humans. J Clin Invest. 1996 Jan 15; 97(2):455-60. Seaquist ER, Kahn SE, Clark PM, Hales CN, Porte D, Robertson RP. PMID: 8567967; PMCID: PMC507037.
      View in: PubMed   Mentions:
    43. The effect of insulin dose on the measurement of insulin sensitivity by the minimal model technique. Evidence for saturable insulin transport in humans. J Clin Invest. 1996 Jan 15; 97(2):501-7. Prigeon RL, Røder ME, Porte D, Kahn SE. PMID: 8567973; PMCID: PMC507043.
      View in: PubMed   Mentions:
    44. The evaluation of insulin as a metabolic signal influencing behavior via the brain. Neurosci Biobehav Rev. 1996; 20(1):139-44. Woods SC, Chavez M, Park CR, Riedy C, Kaiyala K, Richardson RD, Figlewicz DP, Schwartz MW, Porte D, Seeley RJ. PMID: 8622820.
      View in: PubMed   Mentions:
    45. Insulin transport from plasma into the central nervous system is inhibited by dexamethasone in dogs. Diabetes. 1996 Jan; 45(1):86-90. Baura GD, Foster DM, Kaiyala K, Porte D, Kahn SE, Schwartz MW. PMID: 8522065.
      View in: PubMed   Mentions:
    46. Changes in insulin sensitivity, glucose effectiveness, and B-cell function in regularly exercising subjects. Metabolism. 1995 Oct; 44(10):1259-63. Prigeon RL, Kahn SE, Porte D. PMID: 7476281.
      View in: PubMed   Mentions:
    47. The key role of islet dysfunction in type II diabetes mellitus. Clin Invest Med. 1995 Aug; 18(4):247-54. Porte D, Kahn SE. PMID: 8549009.
      View in: PubMed   Mentions:
    48. Glucokinase gene variations in Japanese-Americans with a family history of NIDDM. Diabetes Care. 1994 Dec; 17(12):1480-3. Stone LM, Kahn SE, Deeb SS, Fujimoto WY, Porte D. PMID: 7882822.
      View in: PubMed   Mentions:
    49. Reliability of error estimates from the minimal model: implications for measurements in physiological studies. Am J Physiol. 1994 Feb; 266(2 Pt 1):E279-86. Prigeon RL, Kahn SE, Porte D. PMID: 8141288.
      View in: PubMed   Mentions:
    50. Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. A mechanism for regulated insulin delivery to the brain. J Clin Invest. 1993 Oct; 92(4):1824-30. Baura GD, Foster DM, Porte D, Kahn SE, Bergman RN, Cobelli C, Schwartz MW. PMID: 8408635; PMCID: PMC288346.
      View in: PubMed   Mentions: 130     Fields:    Translation:Animals
    51. Insulin, neuropeptide Y, and food intake. Ann N Y Acad Sci. 1993 Aug 27; 692:60-71. Schwartz MW, Figlewicz DP, Woods SC, Porte D, Baskin DG. PMID: 8215045.
      View in: PubMed   Mentions:
    52. Effect of glucocorticoid and growth hormone treatment on proinsulin levels in humans. Diabetes. 1993 Jul; 42(7):1082-5. Kahn SE, Horber FF, Prigeon RL, Haymond MW, Porte D. PMID: 8513975.
      View in: PubMed   Mentions:
    53. Effect of diet-induced obesity and experimental hyperinsulinemia on insulin uptake into CSF of the rat. Brain Res Bull. 1993; 30(5-6):571-5. Israel PA, Park CR, Schwartz MW, Green PK, Sipols AJ, Woods SC, Porte D, Figlewicz DP. PMID: 8457906.
      View in: PubMed   Mentions:
    54. Insulin in the brain: a hormonal regulator of energy balance. Endocr Rev. 1992 Aug; 13(3):387-414. Schwartz MW, Figlewicz DP, Baskin DG, Woods SC, Porte D. PMID: 1425482.
      View in: PubMed   Mentions:
    55. Effect of fasting on regional levels of neuropeptide Y mRNA and insulin receptors in the rat hypothalamus: An autoradiographic study. Mol Cell Neurosci. 1992 Jun; 3(3):199-205. Marks JL, Li M, Schwartz M, Porte D, Baskin DG. PMID: 19912861.
      View in: PubMed   Mentions:
    56. Short-term hyperglycemia and hyperinsulinemia improve insulin action but do not alter glucose action in normal humans. Am J Physiol. 1992 Apr; 262(4 Pt 1):E518-23. Kahn SE, Bergman RN, Schwartz MW, Taborsky GJ, Porte D. PMID: 1566838.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    57. Effect of insulin resistance and hyperglycemia on proinsulin release in a primate model of diabetes mellitus. J Clin Endocrinol Metab. 1992 Jan; 74(1):192-7. Kahn SE, McCulloch DK, Schwartz MW, Palmer JP, Porte D. PMID: 1727820.
      View in: PubMed   Mentions:
    58. Glucose stimulates and potentiates islet amyloid polypeptide secretion by the B-cell. Horm Metab Res. 1991 Dec; 23(12):577-80. Kahn SE, Fujimoto WY, D'Alessio DA, Ensinck JW, Porte D. PMID: 1723393.
      View in: PubMed   Mentions:
    59. Evidence for entry of plasma insulin into cerebrospinal fluid through an intermediate compartment in dogs. Quantitative aspects and implications for transport. J Clin Invest. 1991 Oct; 88(4):1272-81. Schwartz MW, Bergman RN, Kahn SE, Taborsky GJ, Fisher LD, Sipols AJ, Woods SC, Steil GM, Porte D. PMID: 1918377; PMCID: PMC295596.
      View in: PubMed   Mentions: 48     Fields:    Translation:Animals
    60. Localization of type I insulin-like growth factor receptor messenger RNA in the adult rat brain by in situ hybridization. Mol Endocrinol. 1991 Aug; 5(8):1158-68. Marks JL, Porte D, Baskin DG. PMID: 1658638.
      View in: PubMed   Mentions:
    61. Mechanisms for hyperglycemia in type II diabetes mellitus: therapeutic implications for sulfonylurea treatment--an update. Am J Med. 1991 Jun 24; 90(6A):8S-14S. Porte D, Kahn SE. PMID: 1872310.
      View in: PubMed   Mentions:
    62. Central insulin administration reduces neuropeptide Y mRNA expression in the arcuate nucleus of food-deprived lean (Fa/Fa) but not obese (fa/fa) Zucker rats. Endocrinology. 1991 May; 128(5):2645-7. Schwartz MW, Marks JL, Sipols AJ, Baskin DG, Woods SC, Kahn SE, Porte D. PMID: 2019270.
      View in: PubMed   Mentions:
    63. The glucose intolerance of aging. Implications for intervention. Hosp Pract (Off Ed). 1991 Apr 30; 26(4A):29-38. Kahn SE, Schwartz RS, Porte D, Abrass IB. PMID: 2016375.
      View in: PubMed   Mentions:
    64. Banting lecture 1990. Beta-cells in type II diabetes mellitus. Diabetes. 1991 Feb; 40(2):166-80. Porte D. PMID: 1991568.
      View in: PubMed   Mentions:
    65. Localization of insulin receptor mRNA in rat brain by in situ hybridization. Endocrinology. 1990 Dec; 127(6):3234-6. Marks JL, Porte D, Stahl WL, Baskin DG. PMID: 2249648.
      View in: PubMed   Mentions:
    66. Treatment with a somatostatin analog decreases pancreatic B-cell and whole body sensitivity to glucose. J Clin Endocrinol Metab. 1990 Oct; 71(4):994-1002. Kahn SE, Klaff LJ, Schwartz MW, Beard JC, Bergman RN, Taborsky GJ, Porte D. PMID: 2205630.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    67. Kinetics and specificity of insulin uptake from plasma into cerebrospinal fluid. Am J Physiol. 1990 Sep; 259(3 Pt 1):E378-83. Schwartz MW, Sipols A, Kahn SE, Lattemann DF, Taborsky GJ, Bergman RN, Woods SC, Porte D. PMID: 2205107.
      View in: PubMed   Mentions: 56     Fields:    Translation:Animals
    68. Evidence for separate receptors for insulin and insulin-like growth factor-I in choroid plexus of rat brain by quantitative autoradiography. J Histochem Cytochem. 1990 Sep; 38(9):1289-94. Davidson DA, Bohannon NJ, Corp ES, Lattemann DP, Woods SC, Porte D, Dorsa DM, Baskin DG. PMID: 2167329.
      View in: PubMed   Mentions:
    69. Disproportionately elevated proinsulin in Pima Indians with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1990 May; 70(5):1247-53. Saad MF, Kahn SE, Nelson RG, Pettitt DJ, Knowler WC, Schwartz MW, Kowalyk S, Bennett PH, Porte D. PMID: 2186054.
      View in: PubMed   Mentions:
    70. Insulin binding to brain capillaries is reduced in genetically obese, hyperinsulinemic Zucker rats. Peptides. 1990 May-Jun; 11(3):467-72. Schwartz MW, Figlewicz DF, Kahn SE, Baskin DG, Greenwood MR, Porte D. PMID: 2199946.
      View in: PubMed   Mentions:
    71. Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells. Diabetes. 1990 May; 39(5):634-8. Kahn SE, D'Alessio DA, Schwartz MW, Fujimoto WY, Ensinck JW, Taborsky GJ, Porte D. PMID: 2185112.
      View in: PubMed   Mentions:
    72. Islet function and insulin sensitivity in the non-diabetic offspring of conjugal type 2 diabetic patients. Diabet Med. 1990 Feb; 7(2):119-25. Johnston C, Ward WK, Beard JC, McKnight B, Porte D. PMID: 2137751.
      View in: PubMed   Mentions:
    73. A re-assessment of the regulation of adiposity and appetite by the brain insulin system. Int J Obes. 1990; 14 Suppl 3:69-73; discussion 74-6. Woods SC, Figlewicz Lattemann DP, Schwartz MW, Porte D. PMID: 2086517.
      View in: PubMed   Mentions:
    74. Hyperproinsulinemia and amyloid in NIDDM. Clues to etiology of islet beta-cell dysfunction? Diabetes. 1989 Nov; 38(11):1333-6. Porte D, Kahn SE. PMID: 2695369.
      View in: PubMed   Mentions:
    75. Increased beta-cell secretory capacity as mechanism for islet adaptation to nicotinic acid-induced insulin resistance. Diabetes. 1989 May; 38(5):562-8. Kahn SE, Beard JC, Schwartz MW, Ward WK, Ding HL, Bergman RN, Taborsky GJ, Porte D. PMID: 2653928.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    76. Islet dysfunction in non-insulin-dependent diabetes mellitus. Am J Med. 1988 Nov 28; 85(5A):4-8. Kahn SE, Porte D. PMID: 3057894.
      View in: PubMed   Mentions:
    77. Insulin resistance and beta-cell dysfunction in aging: the importance of dietary carbohydrate. J Clin Endocrinol Metab. 1988 Nov; 67(5):951-7. Chen M, Bergman RN, Porte D. PMID: 3053750.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCTClinical Trials
    78. Penetration of peripheral glucose and insulin into cerebrospinal fluid in rats. Am J Physiol. 1988 Aug; 255(2 Pt 2):R200-4. Steffens AB, Scheurink AJ, Porte D, Woods SC. PMID: 3044143.
      View in: PubMed   Mentions:
    79. Reduction of glycemic potentiation. Sensitive indicator of beta-cell loss in partially pancreatectomized dogs. Diabetes. 1988 Jun; 37(6):723-9. Ward WK, Wallum BJ, Beard JC, Taborsky GJ, Porte D. PMID: 3289992.
      View in: PubMed   Mentions:
    80. Reduced effect of experimental peripheral hyperinsulinemia to elevate cerebrospinal fluid insulin concentrations of obese Zucker rats. Endocrinology. 1987 Nov; 121(5):1611-5. Stein LJ, Dorsa DM, Baskin DG, Figlewicz DP, Porte D, Woods SC. PMID: 3311715.
      View in: PubMed   Mentions:
    81. Disproportionate elevation of immunoreactive proinsulin in type 2 (non-insulin-dependent) diabetes mellitus and in experimental insulin resistance. Diabetologia. 1987 Sep; 30(9):698-702. Ward WK, LaCava EC, Paquette TL, Beard JC, Wallum BJ, Porte D. PMID: 3322910.
      View in: PubMed   Mentions:
    82. Relationship of islet function to insulin action in human obesity. J Clin Endocrinol Metab. 1987 Jul; 65(1):59-64. Beard JC, Ward WK, Halter JB, Wallum BJ, Porte D. PMID: 3294880.
      View in: PubMed   Mentions:
    83. Insulin in the brain. Annu Rev Physiol. 1987; 49:335-47. Baskin DG, Figlewicz DP, Woods SC, Porte D, Dorsa DM. PMID: 3551804.
      View in: PubMed   Mentions:
    84. Localization of 125I-insulin binding sites in the rat hypothalamus by quantitative autoradiography. Neurosci Lett. 1986 Sep 25; 70(1):17-22. Corp ES, Woods SC, Porte D, Dorsa DM, Figlewicz DP, Baskin DG. PMID: 3534636.
      View in: PubMed   Mentions:
    85. Identification of binding sites for an insulin-like growth factor (IGF-I) in the median eminence of the rat brain by quantitative autoradiography. Endocrinology. 1986 Aug; 119(2):943-5. Bohannon NJ, Figlewicz DP, Corp ES, Wilcox BJ, Porte D, Baskin DG. PMID: 3015561.
      View in: PubMed   Mentions:
    86. The insulin sensitivity index in nondiabetic man. Correlation between clamp-derived and IVGTT-derived values. Diabetes. 1986 Mar; 35(3):362-9. Beard JC, Bergman RN, Ward WK, Porte D. PMID: 3512346.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansAnimals
    87. Clinical aspects of islet B-cell function in non-insulin-dependent diabetes mellitus. Diabetes Metab Rev. 1986; 2(3-4):297-313. Ward WK, Beard JC, Porte D. PMID: 3527617.
      View in: PubMed   Mentions:
    88. Insulin: its relationship to the central nervous system and to the control of food intake and body weight. Am J Clin Nutr. 1985 11; 42(5 Suppl):1063-71. Woods SC, Porte D, Bobbioni E, Ionescu E, Sauter JF, Rohner-Jeanrenaud F, Jeanrenaud B. PMID: 3904396.
      View in: PubMed   Mentions:
    89. Brain and liver insulin binding is decreased in Zucker rats carrying the 'fa' gene. Endocrinology. 1985 Oct; 117(4):1537-43. Figlewicz DP, Dorsa DM, Stein LJ, Baskin DG, Paquette T, Greenwood MR, Woods SC, Porte D. PMID: 3896761.
      View in: PubMed   Mentions:
    90. Insulin resistance and impaired insulin secretion in subjects with histories of gestational diabetes mellitus. Diabetes. 1985 Sep; 34(9):861-9. Ward WK, Johnston CL, Beard JC, Benedetti TJ, Halter JB, Porte D. PMID: 3896896.
      View in: PubMed   Mentions:
    91. Glucose regulation in non-insulin-dependent diabetes mellitus. Interaction between pancreatic islets and the liver. Am J Med. 1985 Aug 23; 79(2B):6-12. Halter JB, Ward WK, Porte D, Best JD, Pfeifer MA. PMID: 2863979.
      View in: PubMed   Mentions:
    92. Islet beta-cell function and polymorphism in the 5'-flanking region of the human insulin gene. Diabetes. 1985 Apr; 34(4):311-4. Permutt MA, Rotwein P, Andreone T, Ward WK, Porte D. PMID: 2982683.
      View in: PubMed   Mentions:
    93. Genetically obese Zucker rats have abnormally low brain insulin content. Life Sci. 1985 Feb 18; 36(7):627-33. Baskin DG, Stein LJ, Ikeda H, Woods SC, Figlewicz DP, Porte D, Greenwood MR, Dorsa DM. PMID: 3881641.
      View in: PubMed   Mentions:
    94. Pathophysiology of insulin secretion in diabetes mellitus. Adv Exp Med Biol. 1985; 189:137-58. Ward WK, Beard JC, Halter JB, Porte D. PMID: 3898762.
      View in: PubMed   Mentions:
    95. Pathogenesis of age-related glucose intolerance in man: insulin resistance and decreased beta-cell function. J Clin Endocrinol Metab. 1985 Jan; 60(1):13-20. Chen M, Bergman RN, Pacini G, Porte D. PMID: 3880560.
      View in: PubMed   Mentions: 73     Fields:    Translation:Humans
    96. Dexamethasone-induced insulin resistance enhances B cell responsiveness to glucose level in normal men. Am J Physiol. 1984 Nov; 247(5 Pt 1):E592-6. Beard JC, Halter JB, Best JD, Pfeifer MA, Porte D. PMID: 6388353.
      View in: PubMed   Mentions:
    97. Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Invest. 1984 Oct; 74(4):1318-28. Ward WK, Bolgiano DC, McKnight B, Halter JB, Porte D. PMID: 6384269; PMCID: PMC425299.
      View in: PubMed   Mentions:
    98. Pathophysiology of insulin secretion in non-insulin-dependent diabetes mellitus. Diabetes Care. 1984 Sep-Oct; 7(5):491-502. Ward WK, Beard JC, Halter JB, Pfeifer MA, Porte D. PMID: 6094129.
      View in: PubMed   Mentions:
    99. Islet function and stress hyperglycemia: plasma glucose and epinephrine interaction. Am J Physiol. 1984 Jul; 247(1 Pt 1):E47-52. Halter JB, Beard JC, Porte D. PMID: 6377920.
      View in: PubMed   Mentions:
    100. Adaptation of B and A cell function during prolonged glucose infusion in human subjects. Am J Physiol. 1984 May; 246(5 Pt 1):E405-11. Ward WK, Halter JB, Beard JC, Porte D. PMID: 6372519.
      View in: PubMed   Mentions:
    101. Acute and chronic effects of sulfonylurea drugs on pancreatic islet function in man. Diabetes Care. 1984 May-Jun; 7 Suppl 1:25-34. Pfeifer MA, Halter JB, Judzewitsch RG, Beard JC, Best JD, Ward WK, Porte D. PMID: 6376026.
      View in: PubMed   Mentions:
    102. Immunoreactive insulin levels are elevated in the cerebrospinal fluid of genetically obese Zucker rats. Endocrinology. 1983 Dec; 113(6):2299-301. Stein LJ, Dorsa DM, Baskin DG, Figlewicz DP, Ikeda H, Frankmann SP, Greenwood MR, Porte D, Woods SC. PMID: 6357768.
      View in: PubMed   Mentions:
    103. Immunocytochemical detection of insulin in rat hypothalamus and its possible uptake from cerebrospinal fluid. Endocrinology. 1983 Nov; 113(5):1818-25. Baskin DG, Woods SC, West DB, van Houten M, Posner BI, Dorsa DM, Porte D. PMID: 6354698.
      View in: PubMed   Mentions:
    104. Hyperglycemia and beta-cell adaptation during prolonged somatostatin infusion with glucagon replacement in man. Diabetes. 1983 Oct; 32(10):943-7. Ward WK, Halter JB, Best JD, Beard JC, Porte D. PMID: 6137430.
      View in: PubMed   Mentions:
    105. The response of plasma triglyceride, cholesterol, and lipoprotein lipase to treatment in non-insulin-dependent diabetic subjects without familial hypertriglyceridemia. Diabetes. 1983 Jun; 32(6):525-31. Pfeifer MA, Brunzell JD, Best JD, Judzewitsch RG, Halter JB, Porte D. PMID: 6354782.
      View in: PubMed   Mentions:
    106. Effect of hyperglycemia per se on glucose disposal and clearance in noninsulin-dependent diabetics. J Clin Endocrinol Metab. 1983 Apr; 56(4):819-23. Best JD, Beard JC, Taborsky GJ, Halter JB, Porte D. PMID: 6131903.
      View in: PubMed   Mentions:
    107. Regional concentrations of insulin in the rat brain. Endocrinology. 1983 Mar; 112(3):898-903. Baskin DG, Porte D, Guest K, Dorsa DM. PMID: 6337049.
      View in: PubMed   Mentions:
    108. The role of insulin as a satiety factor in the central nervous system. Adv Metab Disord. 1983; 10:457-68. Woods SC, Porte D. PMID: 6364721.
      View in: PubMed   Mentions:
    109. Glycosylated hemoglobin and fasting plasma glucose in the assessment of outpatient glycemic control in NIDDM. Diabetes Care. 1982 Nov-Dec; 5(6):592-9. Pecoraro RE, Chen MS, Porte D. PMID: 6927729.
      View in: PubMed   Mentions:
    110. Interaction of glucose and epinephrine in the regulation of insulin secretion. Diabetes. 1982 Sep; 31(9):802-7. Beard JC, Weinberg C, Pfeifer MA, Best JD, Halter JB, Porte D. PMID: 6761215.
      View in: PubMed   Mentions:
    111. Chronic chlorpropamide therapy of noninsulin-dependent diabetes augments basal and stimulated insulin secretion by increasing islet sensitivity to glucose. J Clin Endocrinol Metab. 1982 Aug; 55(2):321-8. Judzewitsch RG, Pfeifer MA, Best JD, Beard JC, Halter JB, Porte D. PMID: 7045153.
      View in: PubMed   Mentions:
    112. Quantitative evaluation of cardiac parasympathetic activity in normal and diabetic man. Diabetes. 1982 Apr; 31(4 Pt 1):339-45. Pfeifer MA, Cook D, Brodsky J, Tice D, Reenan A, Swedine S, Halter JB, Porte D. PMID: 7152130.
      View in: PubMed   Mentions:
    113. The effect of chronic sulfonylurea therapy on hepatic glucose production in non-insulin-dependent diabetes. Diabetes. 1982 Apr; 31(4 Pt 1):333-8. Best JD, Judzewitsch RG, Pfeifer MA, Beard JC, Halter JB, Porte D. PMID: 6759249.
      View in: PubMed   Mentions:
    114. Insulin responses to nonglucose stimuli in non-insulin-dependent diabetes mellitus during a tolbutamide infusion. Diabetes. 1982 Feb; 31(2):154-9. Pfeifer MA, Halter JB, Beard JC, Judzewitsch R, Porte D. PMID: 6759232.
      View in: PubMed   Mentions:
    115. Central and peripheral nervous system complications. Diabetes. 1982; 31(Suppl 1 Pt 2):65-70. Brown MR, Dyck PJ, McClearn GE, Sima AA, Powell HC, Porte D. PMID: 6298038.
      View in: PubMed   Mentions:
    116. Differential effects of tolbutamide on first and second phase insulin secretion in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1981 Dec; 53(6):1256-62. Pfeifer MA, Halter JB, Beard JC, Porte D. PMID: 7028776.
      View in: PubMed   Mentions:
    117. Glucose disposal is not proportional to plasma glucose level in man. Diabetes. 1981 Oct; 30(10):847-50. Best JD, Taborsky GJ, Halter JB, Porte D. PMID: 6115785.
      View in: PubMed   Mentions:
    118. The regulation of glucose-induced insulin secretion by pre-stimulus glucose level and tolbutamide in normal man. Diabetologia. 1981 Sep; 21(3):198-205. Pfeifer MA, Graf RJ, Halter JB, Porte D. PMID: 7028551.
      View in: PubMed   Mentions:
    119. Glucose and acetylcholine have different effects on the plateau pacemaker of pancreatic islet cells. Diabetes. 1981 Jul; 30(7):558-61. Cook DL, Crill WE, Porte D. PMID: 7018962.
      View in: PubMed   Mentions:
    120. Endogenous hyperglycemia restores insulin release impaired by somatostatin analogue. Am J Physiol. 1981 Apr; 240(4):E407-13. Taborsky GJ, Porte D. PMID: 6111928.
      View in: PubMed   Mentions:
    121. Insulin secretion in diabetes mellitus. Am J Med. 1981 Mar; 70(3):579-88. Pfeifer MA, Halter JB, Porte D. PMID: 7011013.
      View in: PubMed   Mentions:
    122. Ventromedial hypothalamic lesions increase pancreatic sensitivity to streptozotocin in rats. Diabetes. 1980 Nov; 29(11):948-51. West DB, Seino Y, Woods SC, Porte D. PMID: 6448758.
      View in: PubMed   Mentions:
    123. Potentiation of insulin secretion to nonglucose stimuli in normal man by tolbutamide. Diabetes. 1980 May; 29(5):335-40. Pfeifer MA, Halter JB, Graf R, Porte D. PMID: 6991327.
      View in: PubMed   Mentions:
    124. Comparison of a colorimetric assay for glycosylated hemoglobin with ion-exchange chromatography. Diabetes. 1979 Dec; 28(12):1120-5. Pecoraro RE, Graf RJ, Halter JB, Beiter H, Porte D. PMID: 510809.
      View in: PubMed   Mentions:
    125. Glucose-induced insulin release during acute and chronic hypoxia. Am J Physiol. 1979 Jul; 237(1):E45-50. Baum D, Griepp R, Porte D. PMID: 464052.
      View in: PubMed   Mentions:
    126. Potentiation of insulin secretory responses by plasma glucose levels in man: evidence that hyperglycemia in diabetes compensates for imparied glucose potentiation. J Clin Endocrinol Metab. 1979 Jun; 48(6):946-54. Halter JB, Graf RJ, Porte D. PMID: 447800.
      View in: PubMed   Mentions:
    127. Differential effects of somatostatin analogues on alpha- and beta-cells of the pancreas. Am J Physiol. 1979 Feb; 236(2):E123-8. Taborsky GJ, Smith PH, Porte D. PMID: 369388.
      View in: PubMed   Mentions:
    128. Interaction of somatostatin with the A and B cells of the endocrine pancreas. Metabolism. 1978 Sep; 27(9 Suppl 1):1299-302. Taborsky GJ, Smith PH, Porte D. PMID: 210359.
      View in: PubMed   Mentions:
    129. Glycosylated hemoglobin in normal subjects and subjects with maturity-onset diabetes. Evidence for a saturable system in man. Diabetes. 1978 Aug; 27(8):834-9. Graf RJ, Halter JB, Porte D. PMID: 680410.
      View in: PubMed   Mentions:
    130. Mechanisms of impaired acute insulin release in adult onset diabetes: studies with isoproterenol and secretin. J Clin Endocrinol Metab. 1978 Jun; 46(6):952-60. Halter JB, Porte D. PMID: 400768.
      View in: PubMed   Mentions:
    131. Inhibition of insulin and glucagon secretion by somatostatin: are there indirect effects? Proc Soc Exp Biol Med. 1978 Apr; 157(4):643-7. Smith PH, Chen M, Woods SC, Ensinck JW, Porte D. PMID: 349571.
      View in: PubMed   Mentions:
    132. The central nervous system, pancreatic hormones, feeding, and obesity. Adv Metab Disord. 1978; 9:283-312. Woods SC, Porte D. PMID: 347907.
      View in: PubMed   Mentions:
    133. Neurohumoral regulation of the pancreatic islet A and B cells. Metabolism. 1976 Nov; 25(11 Suppl 1):1453-6. Porte D, Smith PH, Ensinck JW. PMID: 790092.
      View in: PubMed   Mentions:
    134. Phentolamine blocks the somatostatin-mediated inhibition of insulin secretion. Endocrinology. 1976 Apr; 98(4):1073-6. Smith PH, Woods SC, Porte D. PMID: 776596.
      View in: PubMed   Mentions:
    135. A role for alpha-adrenergic receptors in abnormal insulin secretion in diabetes mellitus. J Clin Invest. 1976 Mar; 57(3):791-5. Robertson RP, Halter JB, Porte D. PMID: 1249209; PMCID: PMC436715.
      View in: PubMed   Mentions:
    136. Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests. J Clin Endocrinol Metab. 1976 Feb; 42(2):222-9. Brunzell JD, Robertson RP, Lerner RL, Hazzard WR, Ensinck JW, Bierman EL, Porte D. PMID: 1262429.
      View in: PubMed   Mentions:
    137. Beta adrenergic receptor dysfunction in hypoxic inhibition of insulin release. Endocrinology. 1976 Feb; 98(2):359-66. Baum D, Porte D. PMID: 1248452.
      View in: PubMed   Mentions:
    138. Effect of intracisternal insulin on plasma glucose and insulin in the dog. Diabetes. 1975 Oct; 24(10):905-9. Woods SC, Porte D. PMID: 1100459.
      View in: PubMed   Mentions:
    139. Effect of cerebral intraventricular insulin on pancreatic insulin secretion in the dog. Diabetes. 1975 Oct; 24(10):910-4. Chen M, Woods SC, Porte D. PMID: 1100460.
      View in: PubMed   Mentions:
    140. Central factors in the control of insulin and glucagon secretion. Pharmacol Biochem Behav. 1975; 3(1 Suppl):127-33. Porte D, Woods SC, Chen M, Smith PH, Ensinck JW. PMID: 775499.
      View in: PubMed   Mentions:
    141. Plasma catecholamine responses to intravenous glucose in normal man. J Clin Endocrinol Metab. 1974 Aug; 39(2):403-5. Robertson RP, Porte D. PMID: 4422014.
      View in: PubMed   Mentions:
    142. Inhibition of in vivo insulin secretion by prostaglandin E1. J Clin Invest. 1974 Aug; 54(2):310-5. Robertson RP, Gavareski DJ, Porte D, Bierman EL. PMID: 4847247; PMCID: PMC301558.
      View in: PubMed   Mentions:
    143. Effect of phenformin on glucose-insulin interrelationships. Diabetes. 1974 Jul; 23(7):624-30. Stout RW, Brunzell JD, Bierman EL, Porte D. PMID: 4841569.
      View in: PubMed   Mentions:
    144. Neural control of the endocrine pancreas. Physiol Rev. 1974 Jul; 54(3):596-619. Woods SC, Porte D. PMID: 4601624.
      View in: PubMed   Mentions:
    145. Basal and stimulated hyperinsulinism: reversible metabolic sequelae of obesity. J Lab Clin Med. 1974 Apr; 83(4):563-9. Bagdade JD, Porte D, Brunzell JD, Bierman EL. PMID: 4817780.
      View in: PubMed   Mentions:
    146. Effect of a fat free, high carbohydrate diet on diabetic subjects with fasting hyperglycemia. Diabetes. 1974 Feb; 23(2):138-42. Brunzell JD, Lerner RL, Porte D, Bierman EL. PMID: 4811509.
      View in: PubMed   Mentions:
    147. Control of insulin secretion by catecholamines, stress, and the sympathetic nervous system. Fed Proc. 1973 Jul; 32(7):1792-6. Porte D, Robertson RP. PMID: 4352448.
      View in: PubMed   Mentions:
    148. Glucagon release induced by pancreatic nerve stimulation in the dog. J Clin Invest. 1973 May; 52(5):1246-59. Marliss EB, Girardier L, Seydoux J, Wollheim CB, Kanazawa Y, Orci L, Renold AE, Porte D. PMID: 4349486; PMCID: PMC302381.
      View in: PubMed   Mentions:
    149. The glucose receptor. A defective mechanism in diabetes mellitus distinct from the beta adrenergic receptor. J Clin Invest. 1973 Apr; 52(4):870-6. Robertson RP, Porte D. PMID: 4693651; PMCID: PMC302334.
      View in: PubMed   Mentions:
    150. Abnormal alpha-adrenergic mechanisms in diabetes mellitus. Lancet. 1973 Feb 17; 1(7799):370. Robertson RP, Beiter HL, Porte D. PMID: 4121958.
      View in: PubMed   Mentions:
    151. Neural regulation of insulin secretion in the dog. J Clin Invest. 1973 Jan; 52(1):210-4. Porte D, Girardier L, Seydoux J, Kanazawa Y, Posternak J. PMID: 4682384; PMCID: PMC302245.
      View in: PubMed   Mentions:
    152. Adrenergic modulation of basal insulin secretion in man. Diabetes. 1973 Jan; 22(1):1-8. Robertson RP, Porte D. PMID: 4683792.
      View in: PubMed   Mentions:
    153. Paradoxical hypoinsulinaemia: an alpha-adrenergic-mediated response to glucose. Lancet. 1972 Oct 14; 2(7781):787-9. Robertson RP, Brunzell JD, Hazzard WR, Lerner RL, Porte D. PMID: 4116230.
      View in: PubMed   Mentions:
    154. Studies of secretin-stimulated insulin responses in man. J Clin Invest. 1972 Aug; 51(8):2205-10. Lerner RL, Porte D. PMID: 4559947; PMCID: PMC292378.
      View in: PubMed   Mentions:
    155. Acute and steady-state insulin responses to glucose in nonobese diabetic subjects. J Clin Invest. 1972 Jul; 51(7):1624-31. Lerner RL, Porte D. PMID: 4555783; PMCID: PMC292309.
      View in: PubMed   Mentions:
    156. A mechanism for regulation of insulin release in hypoxia. Am J Physiol. 1972 Mar; 222(3):695-9. Baum D, Porte D. PMID: 4401851.
      View in: PubMed   Mentions:
    157. Counter-regulation of basal insulin secretion during alcohol hypoglycemia in diabetic and normal subjects. Diabetes. 1972 Feb; 21(2):65-70. Bagdade JD, Bierman EL, Porte D. PMID: 5060106.
      View in: PubMed   Mentions:
    158. Conditioned insulin secretion and hypoglycemia following repeated injections of tolbutamide in rats. Endocrinology. 1972 Jan; 90(1):227-31. Woods SC, Alexander KR, Porte D. PMID: 5009061.
      View in: PubMed   Mentions:
    159. Epinephrine: selective inhibition of the acute insulin response to glucose. J Clin Invest. 1971 Nov; 50(11):2453-7. Lerner RL, Porte D. PMID: 4938132; PMCID: PMC292188.
      View in: PubMed   Mentions:
    160. Basal and stimulated insulin levels: comparison of insulinogenic effects of oral glucose and intravenous tolbutamide in nondiabetic and diabetic subjects. Metabolism. 1971 Nov; 20(11):1000-7. Bagdade JD, Bierman EL, Porte D. PMID: 5115750.
      View in: PubMed   Mentions:
    161. Influence of obesity on the relationship between insulin and triglyceride levels in endogenous hypertriglyceridemia. Diabetes. 1971 Oct; 20(10):664-72. Bagdade JD, Bierman EL, Porte D. PMID: 5110698.
      View in: PubMed   Mentions:
    162. Uniphasic insulin responses to secretin stimulation in man. J Clin Invest. 1970 Dec; 49(12):2276-80. Lerner RL, Porte D. PMID: 5480853; PMCID: PMC322729.
      View in: PubMed   Mentions:
    163. The critical role of obesity in the interpretation of serum insulin levels. Adv Metab Disord. 1970; 1:Suppl 1:191+. Porte D, Bagdade JD, Bierman EL. PMID: 5430673.
      View in: PubMed   Mentions:
    164. Hypertriglyceridemia and glucose intolerance in man. Horm Metab Res. 1970; 2:Suppl 2:209-12. Bierman EL, Porte D, Bagdade JD. PMID: 4949048.
      View in: PubMed   Mentions:
    165. Human insulin secretion: as integrated approach. Annu Rev Med. 1970; 21:219-40. Porte D, Bagdade JD. PMID: 4913946.
      View in: PubMed   Mentions:
    166. The interaction of diabetes and obesity on the regulation of fat mobilization in man. Diabetes. 1969 Nov; 18(11):759-72. Bagdade JD, Porte D, Bierman EL. PMID: 4900006.
      View in: PubMed   Mentions:
    167. Sympathetic regulation of insulin secretion. Its relation to diabetes mellitus. Arch Intern Med. 1969 Mar; 123(3):252-60. Porte D. PMID: 4974823.
      View in: PubMed   Mentions:
    168. Inhibition of insulin release by diazoxide and its relation to catecholamine effects in man. Ann N Y Acad Sci. 1968 Apr 11; 150(2):281-91. Porte D. PMID: 4299220.
      View in: PubMed   Mentions:
    169. Acute insulin withdrawal and the regulation of plasma triglyceride removal in diabetic subjects. Diabetes. 1968 Mar; 17(3):127-32. Bagdade JD, Porte D, Bierman EL. PMID: 5638574.
      View in: PubMed   Mentions:
    170. Adrenergic regulation of the inhibition of insulin release in hypothermia. Diabetes. 1968; 17:298-9. Baum D, Porte D. PMID: 5651716.
      View in: PubMed   Mentions:
    171. Beta adrenergic stimulation of insulin release in man. Diabetes. 1967 Mar; 16(3):150-5. Porte D. PMID: 5335536.
      View in: PubMed   Mentions:
    172. Inhibition of insulin release by norepinephrine in man. Science. 1966 May 27; 152(3726):1248-50. Porte D, Williams RH. PMID: 5327883.
      View in: PubMed   Mentions:
    173. Clinical use of diazoxide and mechanism for its hyperglycemic effects. Diabetes. 1966 Mar; 15(3):143-8. Graber AL, Porte D, Williams RH. PMID: 4286307.
      View in: PubMed   Mentions:
    174. CHARACTERIZATION OF FAT PARTICLES IN PLASMA OF HYPERLIPEMIC SUBJECTS MAINTAINED ON FAT-FREE HIGH-CARBOHYDRATE DIETS. J Clin Invest. 1965 Feb; 44:261-70. BIERMAN EL, PORTE D, O'HARA DD, SCHWARTZ M, WOOD FC. PMID: 14260869; PMCID: PMC292474.
      View in: PubMed   Mentions:
    Daniel's Networks
    Concepts (449)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (943)
    People in Profiles who have published with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSD Profiles is managed by the UC San Diego Altman Clinical and Translational Research Institute (ACTRI).
    This site is running Profiles RNS version UCSF-v3.1.0-21-g9d46e6c4 on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California